The right place for IL-1 inhibition in COVID-19
Giulio Cavalli, Lorenzo Dagna
Topics & Concepts
Cytokine stormMedicineAnakinraCytokine release syndromeCoronavirus disease 2019 (COVID-19)TocilizumabImmunosuppressionMethylprednisoloneCytokineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicImmunologyInternal medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesInflammasome and immune disordersLong-Term Effects of COVID-19